Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism

Folia Microbiologica

Volumn 56, Issue 4, 2011, Pages 349-352

  de Quadros, Andreza Urba ^a   Bini, Daniel ^a   Pereira, Priscilla Aparecida Tartari ^a   Moroni, Estela Glória ^b   Monteiro, Marta Chagas ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Universidade Estadual do Centro Oeste UNICENTRO   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BIOFILM; CANDIDA ALBICANS; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS;

CANDIDA ALBICANS;

EID: 80051814737     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-011-0049-6     Document Type: Article

References (20)

1. Alem MAS, Douglas LJ (2004) Effects of aspirin and other nosteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 48: 41-47.
2. Alem MAS, Douglas LJ (2005) Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54: 1001-1005.
3. Amann R, Peskar BA (2002) Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 447: 1-9.
4. Bordon AP, Dias-Melicio LA, Acorci MJ et al (2007) Prostaglandin E2 production by high and low virulent strains of Paracoccidioides brasiliensis. Mycopathologia 163: 129-135.
5. Carrillo-Munoz AJ, Giusano G, Ezkurra PA et al (2006) Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter 19: 130-139.
6. Deva R, Ciccoli R, Kock L, Nigam S (2001) Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiol Lett 198: 37-43.
7. Ells R, Kock JLF, Albertyn J, Kemp G, Pohl CH (2011) Effect of inhibitors of arachidonic acid metabolism on prostaglandin E2 production by Candida albicans and Candida dubliniensis biofilms. Med Microbiol Immunol 200: 23-28.
8. Erb-Downward JR, Noverr MC (2007) Characterization of prostaglandin E2 production by Candida albicans. Infect Immun 75: 3498-3505.
9. Erb-Downward JR, Noggle RM, Williamson PR, HuVnagle GB (2008) The role of laccase in prostaglandin production by Cryptococcus neoformans. Mol Microbiol 68: 1428-1437.
10. Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A3, 3rd edition. CLSI, Wayne, PA.
11. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1994) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci 90: 11693-11697.
12. Noverr MC, Phare SM, Toews GB, Coffey MJ, Huffnagle GB (2001) Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69: 2957-2963.
13. Noverr MC, Toews GB, Huffnagle GB (2002) Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 70: 400-402.
14. Pina-Vaz C, Sansonetty F, Rodrigues AG, Oliveira JM, Fonseca AF, Mårdh PA (2000) Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 49: 831-840.
15. Sanyal AK, Roy D, Chowdhury B, Banerjee AB (1993) Ibuprofen, a unique anti-inflammatory compound with antifungal activity against dermatophytes. Lett Appl Microbiol 17: 109-111.
16. Scott EM, Tariq VN, McCrory RM (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother 39: 2610-2614.
17. Tariq VN, Scott EM, McCain NE (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother 12: 2615-2619.
18. Trofa D, Agovino M, Stehr F, Schafer W, Rykunov D, Fiser A, Hamari Z, Nosanchuk JD, Gácser A (2009) Acetylsalicylic acid (aspirin) reduces damage to reconstituted human tissues infected with Candida species by inhibiting extracellular fungal lipases. Microbes Infect 11: 1131-1139.
19. Vane JR, Botting RM (1998) Mechanism of action of antiinflammatory drugs. Int J Tis Reactions-Exp Clin Asp 20: 3-15.
20. Wu KK (2000) Aspirin and salicylate: an old remedy with a new twist. Circulation 102: 2022-2023.